These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54 related articles for article (PubMed ID: 26562402)
21. The role of therapy with aminoglycoside in the outcomes of kidney transplant recipients infected with polymyxin- and carbapenem-resistant Enterobacteriaceae. Freire MP; de Oliveira Garcia D; Cury AP; Francisco GR; Dos Santos NF; Spadão F; Bueno MFC; Camargo CH; de Paula FJ; Rossi F; Nahas WC; David-Neto E; Pierrotti LC Eur J Clin Microbiol Infect Dis; 2019 Apr; 38(4):755-765. PubMed ID: 30680569 [TBL] [Abstract][Full Text] [Related]
22. [Clinical impact of infections with carbapenem-resistant enterobacteriaceae in liver transplant recipients]. Lübbert C; Hau HM; Rodloff A; Mössner J; Mischnik A; Bercker S; Bartels M; Kaisers UX Z Gastroenterol; 2015 Nov; 53(11):1276-87. PubMed ID: 26562402 [TBL] [Abstract][Full Text] [Related]
24. Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies. Pouch SM; Satlin MJ Virulence; 2017 May; 8(4):391-402. PubMed ID: 27470662 [TBL] [Abstract][Full Text] [Related]
25. Carbapenem-resistant enterobacteriaceae: an emerging problem in children. Logan LK Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827 [TBL] [Abstract][Full Text] [Related]
26. Multidrug-resistant bacterial infections after liver transplantation: an ever-growing challenge. Santoro-Lopes G; de Gouvêa EF World J Gastroenterol; 2014 May; 20(20):6201-10. PubMed ID: 24876740 [TBL] [Abstract][Full Text] [Related]
27. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control. Tängdén T; Giske CG J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628 [TBL] [Abstract][Full Text] [Related]
28. [Carbapenem-resistant Enterobacteriaceae (CRE): a menace to the public and the mechanisms of antimicrobial resistance]. Nakano R Jpn J Antibiot; 2016 Apr; 69(2):81-9. PubMed ID: 27544976 [TBL] [Abstract][Full Text] [Related]
29. Treatment for infections with carbapenem-resistant Enterobacteriaceae: what options do we still have? Yamamoto M; Pop-Vicas AE Crit Care; 2014 Jun; 18(3):229. PubMed ID: 25041592 [TBL] [Abstract][Full Text] [Related]
32. [KPC carbapenemases: what is at stake in clinical microbiology?]. Cuzon G; Naas T; Nordmann P Pathol Biol (Paris); 2010 Feb; 58(1):39-45. PubMed ID: 19854586 [TBL] [Abstract][Full Text] [Related]
33. Extended-spectrum beta-lactamase-producing bacterial infections in adult solid organ transplant recipients. Winters HA; Parbhoo RK; Schafer JJ; Goff DA Ann Pharmacother; 2011 Mar; 45(3):309-16. PubMed ID: 21386016 [TBL] [Abstract][Full Text] [Related]
34. Carbapenemase-producing organisms in solid organ transplantation. Wong D; van Duin D Curr Opin Organ Transplant; 2019 Aug; 24(4):490-496. PubMed ID: 31169529 [TBL] [Abstract][Full Text] [Related]
35. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. Schwaber MJ; Carmeli Y Clin Infect Dis; 2014 Mar; 58(5):697-703. PubMed ID: 24304707 [TBL] [Abstract][Full Text] [Related]
36. How to stem the tide of carbapenemase-producing enterobacteriaceae?: proactive versus reactive strategies. Bilavsky E; Schwaber MJ; Carmeli Y Curr Opin Infect Dis; 2010 Aug; 23(4):327-31. PubMed ID: 20581673 [TBL] [Abstract][Full Text] [Related]
37. Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae. Wong D; Spellberg B Virulence; 2017 May; 8(4):383-390. PubMed ID: 27187821 [TBL] [Abstract][Full Text] [Related]
38. Bloodstream infections after solid-organ transplantation. Kritikos A; Manuel O Virulence; 2016 Apr; 7(3):329-40. PubMed ID: 26766415 [TBL] [Abstract][Full Text] [Related]